Establishing a Chemical Genetic Link Between Bruton Tyrosine Kinase Activity in Malignant B Cells and Cell Functions Involved in the Micro-Environmental Dialogue

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14781
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

the Specific Bruton Tyrosine Kinase Inhibitor Acalabrutinib (ACP-196) Shows Favorable in Vitro Activity Against Chronic Lymphocytic Leukemia B Cells With CD20 Antibodies

Haematologica
Hematology
2017English

Novel Bruton's Tyrosine Kinase Inhibitors Currently in Development

OncoTargets and Therapy
OncologyPharmacology
2013English

Interleukin 2 Regulates the Activity of the Lyn Protein-Tyrosine Kinase in a B-Cell Line.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model

Transplantation
Transplantation
2017English

New and Emerging Bruton Tyrosine Kinase Inhibitors for Treating Mantle Cell Lymphoma – Where Do They Fit In?

Expert Review of Hematology
Hematology
2018English

HGF Induces Novel EGFR Functions Involved in Resistance Formation to Tyrosine Kinase Inhibitors

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Bruton Tyrosine Kinase Inhibitor ONO/GS-4059: From Bench to Bedside

Oncotarget
Oncology
2016English

A Novel Isoform of the B Cell Tyrosine Kinase BTK Protects Breast Cancer Cells From Apoptosis

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2013English

The Phosphoinositide 3-Kinase Signaling Pathway in Normal and Malignant B Cells: Activation Mechanisms, Regulation and Impact on Cellular Functions

Frontiers in Immunology
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy